Alternative Medicine

Ashwagandha: What the Trials Actually Show — and What the Regulators Found

The adaptogen is one of the most-studied botanicals on the supplement shelf, with more than $165 million in annual U.S. sales. The stress data is better than most herbs can claim, the safety story is worse than most buyers assume, and one European country has made it illegal to sell.

Revuelt Health · October 20, 2026 · 10 min read

Continuous Glucose Monitors for People Without Diabetes: Optimization or Expensive Guesswork

The sensors were built to keep people with diabetes safe. Sold to everyone else as a metabolic dashboard, the data on what the numbers actually mean for a healthy body is thinner than the marketing suggests.

Revuelt Health · September 15, 2026 · 9 min read

Cold Plunges: What the Evidence Says You're Trading

Stress and soreness improve. Muscle protein synthesis does not, and in some studies neither does glucose tolerance. Almost every disagreement in this literature turns out to be a disagreement about timing.

Revuelt Health · August 9, 2026 · 8 min read

Hyperbaric Oxygen and the Longevity Claim

A pressurised chamber, sixty sessions, and a telomere finding that launched an industry. The cognitive data is stronger than the anti-ageing data, and it is not the data being sold.

Revuelt Health · August 9, 2026 · 9 min read

Acupuncture for Chronic Pain: What the Guidelines Actually Say

A majority of clinical practice guideline recommendations support it. Almost none of them support it strongly. Both facts come from the same review, and the gap between them is the whole story.

Revuelt Health · August 9, 2026 · 9 min read

Who Actually Shapes Functional Medicine — and What Their Evidence Looks Like

Six figures define the field's centre of gravity. Read against the primary literature, their records are far more uneven than the field's marketing suggests.

Revuelt Health · July 28, 2026 · 12 min read

Five Developments Moving Functional Medicine Toward Actual Evidence

Continuous glucose data, microbiome-guided nutrition, multi-omics baselines, GLP-1 integration and standardised outcome measures — what is maturing, and what is still marketing.

Revuelt Health · July 24, 2026 · 10 min read

Functional Medicine, Explained Without the Hype

A clinical framework, a business model, and a critique — held apart long enough to see what is actually on offer.

Revuelt Health · June 16, 2026 · 8 min read

Updated August 3, 2026